SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-19-005565
Filing Date
2019-04-02
Accepted
2019-04-02 06:19:40
Documents
15

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424b3040119_adialpharma.htm 424B3 1442355
2 GRAPHIC image_001.jpg GRAPHIC 28991
3 GRAPHIC image_002.jpg GRAPHIC 40931
4 GRAPHIC image_003.jpg GRAPHIC 29605
5 GRAPHIC image_004.jpg GRAPHIC 31775
6 GRAPHIC image_005.jpg GRAPHIC 55493
7 GRAPHIC image_006.jpg GRAPHIC 15759
8 GRAPHIC image_007.jpg GRAPHIC 16612
9 GRAPHIC image_008.jpg GRAPHIC 20548
10 GRAPHIC image_009.jpg GRAPHIC 23861
11 GRAPHIC image_010.jpg GRAPHIC 15759
12 GRAPHIC image_011.jpg GRAPHIC 16612
13 GRAPHIC image_012.jpg GRAPHIC 16494
14 GRAPHIC image_013.jpg GRAPHIC 19637
15 GRAPHIC logo_101.jpg GRAPHIC 22238
  Complete submission text file 0001213900-19-005565.txt   1933412
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-230470 | Film No.: 19722717
SIC: 2834 Pharmaceutical Preparations